Insider Trading History of Tananbaum James B.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tananbaum James B. since year 2005. The trader's CIK number is 1581754. At the time of the last reporting, Tananbaum James B. was the 10% Owner of 10x Genomics, Inc. . (stock ticker symbol TXG). See this page for all insider trading activities at 10x Genomics, Inc. .

Note that in the past Tananbaum James B. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Tananbaum James B. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-09-12 TXG 10x Genomics, Inc. Buy 187,500 39.00 7,312,500
2019-09-04 AERI Aerie Pharmaceuticals Inc Buy 100,200 18.48 1,851,696
2019-09-05 AERI Aerie Pharmaceuticals Inc Buy 15,700 18.42 289,194
2019-08-30 AERI Aerie Pharmaceuticals Inc Buy 25,000 21.36 534,000
2019-09-03 AERI Aerie Pharmaceuticals Inc Buy 50,000 21.00 1,049,750
2019-08-21 AERI Aerie Pharmaceuticals Inc Buy 1,153 23.25 26,807
2019-08-23 AERI Aerie Pharmaceuticals Inc Buy 38,300 23.42 896,986
2019-08-22 AERI Aerie Pharmaceuticals Inc Buy 6,700 23.68 158,656
2019-08-16 AERI Aerie Pharmaceuticals Inc Buy 100,000 24.23 2,423,000
2019-08-19 AERI Aerie Pharmaceuticals Inc Buy 3,847 23.34 89,788
2019-08-20 AERI Aerie Pharmaceuticals Inc Buy 50,000 23.21 1,160,500
2019-08-12 AERI Aerie Pharmaceuticals Inc Buy 189,555 24.43 4,630,828
2019-08-13 AERI Aerie Pharmaceuticals Inc Buy 250,000 25.22 6,305,000
2019-08-14 AERI Aerie Pharmaceuticals Inc Buy 100,000 23.73 2,373,000
2017-05-26 AERI Aerie Pharmaceuticals Inc Sale 20,000 55.95 1,119,000
2016-10-06 AERI Aerie Pharmaceuticals Inc Sale 50,000 40.34 2,017,000
2016-07-22 AERI Aerie Pharmaceuticals Inc Buy 250,000 17.50 4,375,000
2016-05-31 AIMT Aimmune Therapeutics, Inc. Sale 240,000 15.23 3,654,720
2015-08-24 AIMT Aimmune Therapeutics, Inc. Buy 25,485 19.66 500,907
2015-08-11 AIMT Aimmune Therapeutics, Inc. Buy 642,035 17.50 11,235,612
2013-05-21 AMBI Ambit Biosciences Corp Buy 1,811 6.84 12,379
2013-05-20 AMBI Ambit Biosciences Corp Buy 8,120 6.90 56,044
2013-06-03 AMBI Ambit Biosciences Corp Buy 10,000 6.99 69,910
2013-06-14 AMBI Ambit Biosciences Corp Buy 7,500 7.46 55,965
2013-05-17 AMBI Ambit Biosciences Corp Buy 36,616 6.77 247,963
2013-06-24 AMBI Ambit Biosciences Corp Buy 4,817 6.77 32,591
2013-06-12 AMBI Ambit Biosciences Corp Buy 5,700 7.45 42,482
2013-05-22 AMBI Ambit Biosciences Corp Buy 5,005 6.74 33,728

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tananbaum James B. (10% Owner of 10x Genomics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month